The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Aug. 06, 2015
Applicant:

Brown University, Providence, RI (US);

Inventors:

Wolfgang Peti, Barrington, RI (US);

Rebecca Page, Barrington, RI (US);

Assignee:

BROWN UNIVERSITY, Providence, RI (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); C07K 14/47 (2006.01); C12N 9/16 (2006.01); A61K 33/06 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4703 (2013.01); A61K 33/06 (2013.01); A61K 38/1738 (2013.01); C12N 9/16 (2013.01); C07K 2319/23 (2013.01); C07K 2319/24 (2013.01);
Abstract

Therapeutic compositions for treatment of protein serine/threonine phosphatase-related diseases are obtained by engineering amino acid sequences that disrupt interaction between the protein serine/threonine phosphatase and a protein inhibitor and are provided herein. Calcineurin and PPI are examples of protein serine/threonine phosphatases. RCAN1 is an inhibitor of calcineurin and is overexpressed in patients with serious diseases, such as Down syndrome and Alzheimer's disease. Molecules that bind RCAN1 at regions that interact with calcineurin selectively modulate functions of calcineurin to treat these diseases. Methods of treating a subject for a protein serine/threonine phosphatase-related disease by administering a molecule having an amino acid sequence selected from the group of SEQ ID NOs: 1-19 are further provided.


Find Patent Forward Citations

Loading…